LONDON — The U.K. government on Friday announced a partnership with German firm BioNTech to test potential vaccines for cancer and other diseases, as campaigners warned any breakthrough must remain affordable and accessible.
Original Article: BioNTech says it will start cancer vaccine trials in the UK from September (cnbc.com)
